Pathstone Family Office, LLC Chimerix Inc Transaction History

Pathstone Family Office, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 14, 2021	SELL	$4.76 - $11.25 $7,616 - $18,000	-1,600 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$1.33 - $3.63 $2,128 - $5,808	-1,600 Closed	0 $0
Q1 2020 Jun 11, 2020	BUY	$1.27 - $2.33 $2,032 - $3,728	1,600 New	1,600 $2,000
Q4 2019 Feb 14, 2020	SELL	$1.3 - $2.72 $2,080 - $4,352	-1,600 Closed	0 $0
Q4 2017 Feb 12, 2018	BUY	$4.32 - $5.52 $6,912 - $8,832	1,600 New	1,600 $7,000
Q3 2017 Nov 14, 2017	SELL	$4.35 - $5.25 $6,959 - $8,400	-1,600 Closed	0 $0
Q2 2017 Aug 16, 2017	BUY	N/A	1,600	1,600 $9,000

37M

52.7K

130K

Ticker CMRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,622,896
Market Cap $75.4M
Description
Chimerix, Inc., a biopharmaceutical company, develops medicines to enhance the lives of patients living with serious diseases. The company's approved product is TEMBEXA (brincidofovir), a lipid conjugate through inhibition of viral DNA synthesis that is developed as a medical countermeasure for smallpox. Its clinical stage development programs i...

Get notified when there are updates to the investment portfolio of Pathstone Family Office, LLC, based on Form 13F filings with the SEC.

Stay updated on Pathstone Family Office, LLC with notifications on news.